116 related articles for article (PubMed ID: 32750560)
1. sTAM: An Online Tool for the Discovery of miRNA-Set Level Disease Biomarkers.
Shi J; Cui Q
Mol Ther Nucleic Acids; 2020 Sep; 21():670-675. PubMed ID: 32750560
[TBL] [Abstract][Full Text] [Related]
2. Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma.
Song R; Liu Q; Hutvagner G; Nguyen H; Ramamohanarao K; Wong L; Li J
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S16. PubMed ID: 25521201
[TBL] [Abstract][Full Text] [Related]
3. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
[TBL] [Abstract][Full Text] [Related]
4. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
5. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
6. PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data.
Goswami CP; Nakshatri H
J Clin Bioinforma; 2012 Dec; 2(1):23. PubMed ID: 23272654
[TBL] [Abstract][Full Text] [Related]
7. Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.
Yu N; Yong S; Kim HK; Choi YL; Jung Y; Kim D; Seo J; Lee YE; Baek D; Lee J; Lee S; Lee JE; Kim J; Kim J; Lee S
Mol Oncol; 2019 Jun; 13(6):1356-1368. PubMed ID: 30913346
[TBL] [Abstract][Full Text] [Related]
8. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
10. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
11. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
12. Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
Lee E; Ito K; Zhao Y; Schadt EE; Irie HY; Zhu J
Bioinformatics; 2016 Jan; 32(1):96-105. PubMed ID: 26358730
[TBL] [Abstract][Full Text] [Related]
13. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.
Lin Y; Wu W; Sun Z; Shen L; Shen B
RNA Biol; 2018; 15(8):1093-1105. PubMed ID: 30081733
[TBL] [Abstract][Full Text] [Related]
15. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
17. Discovering functional impacts of miRNAs in cancers using a causal deep learning model.
Chen L; Lu X
BMC Med Genomics; 2018 Dec; 11(Suppl 6):116. PubMed ID: 30598118
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
[TBL] [Abstract][Full Text] [Related]
19. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
20. Identification of core miRNA based on small RNA-seq and RNA-seq for colorectal cancer by bioinformatics.
Kou Y; Qiao L; Wang Q
Tumour Biol; 2015 Apr; 36(4):2249-55. PubMed ID: 25412953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
